Leveraging Atlas Antibodies from Human Protein Atlas for Insights into Precision Medicine in Cancer
Want to share this FREE webinar with a colleague?
Fill out the form below and we'll send your colleague an invitation to the "Leveraging Atlas Antibodies from Human Protein Atlas for Insights into Precision Medicine in Cancer" event.
Advancements in antibody technologies and protein data are driving new possibilities in cancer research, enabling the identification of novel biomarkers and enhancing therapeutic strategies.
In this webinar, Dr. Eugenia Kuteeva will explore how Atlas Antibodies, developed from the Human Protein Atlas, can support biomarker discovery, improve patient stratification and refine therapeutic targeting in precision oncology. She will also introduce MolBoolean, an innovative in situ proximity tool, unlocking deeper insights into cancer biology.
We’re also excited to welcome Dr. Trevor Pitcher from Biodesix, who will discuss the future of cancer diagnostics and how ddPCR is advancing clinical research that enables the rapid identification of actionable mutations to drive personalized therapeutic strategies.
By attending this webinar, you will learn:
- How Atlas Antibodies can aid in biomarker identification and precision medicine strategies
- The role of MolBoolean in exploring molecular interactions and pathways
- Cutting-edge approaches to advancing cancer research and therapeutic development
- How ddPCR enables rapid and highly sensitive detection of actionable mutations for personalized cancer therapy research
Sponsored by
Have a question about our online events and webinars?
Get in touch here.
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
